EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells

Aruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, Yaxia Yuan, Daohong Zhou, Montaser Shaheen, Doraid T Sadideen, Austin Kirby, Elizabeth A Williamson, Yogesh K Gupta iD, Shaun K Olsen, Mingjiang Xu und 7 weitere

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Aruna S Jaiswal und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and the Mays Cancer Center, the University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1-deficient cells have increased IRE1 RNase, which degrades multiple microRNAs. Reconstituting expression of one of these, miR-4638–5p, resulted in synthetic lethality in BRCA1-deficient cancer cells. We found that miR-4638-5p represses expression of TATDN2, a poorly characterized member of the TATD nuclease family. We discovered that human TATDN2 has RNA 3′ exonuclease and endonuclease activity on double-stranded hairpin RNA structures. Given the cleavage of hairpin RNA by TATDN2, and that BRCA1-deficient cells have difficulty resolving R-loops, we tested whether TATDN2 could resolve R-loops. Using in vitro biochemical reconstitution assays, we found TATDN2 bound to R-loops and degraded the RNA strand but not DNA of multiple forms of R-loops in vitro in a Mg2+-dependent manner. Mutations in amino acids E593 and E705 predicted by Alphafold-2 to chelate an essential Mg2+ cation completely abrogated this R-loop resolution activity. Depleting TATDN2 increased cellular R-loops, DNA damage and chromosomal instability. Loss of TATDN2 resulted in poor replication fork progression in the presence of increased R-loops. Significantly, we found that TATDN2 is essential for survival of BRCA1-deficient cancer cells, but much less so for cognate BRCA1-repleted cancer cells. Thus, we propose that TATDN2 is a novel target for therapy of BRCA1-deficient cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansBRCA1 ProteinDNA ReplicationGenomic InstabilityMagnesiumMicroRNAsR-Loop StructuresRNA, Long Noncoding

Substanzen

BRCA1 ProteinMagnesiumMicroRNAsBRCA1 protein, humanlong non-coding RNA TATDN1, humanRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Medicine and the Mays Cancer Center, the University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
  • Department of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, the University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
  • Department of Molecular Medicine and the Mays Cancer Center, the University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
  • Department of Cell Systems and Anatomy and the Greehey Children's Cancer Research Institute, the University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
  • Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.

ORCID-Profile: Yogesh K Gupta, Alexander Pertsemlidis, Alexander J R Bishop, Jac A Nickoloff, Robert Hromas

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • Cancer Prevention and Research Institute of Texas
  • NIH
  • American Lung Association
  • Center for Innovative Drug Discovery

Zitieren

APA

Jaiswal, A. S., Dutta, A., Srinivasan, G., Yuan, Y., Zhou, D., Shaheen, M., Sadideen, D. T., Kirby, A., Williamson, E. A., Gupta, Y. K., Olsen, S. K., Xu, M., Loranc, E., Mukhopadhyay, P., Pertsemlidis, A., Bishop, A. J. R., Sung, P., Nickoloff, J. A., & Hromas, R. (2023). TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad952

Vancouver

Jaiswal AS, Dutta A, Srinivasan G, Yuan Y, Zhou D, Shaheen M, et al. TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad952

BibTeX
@article{Jaiswal2023,
  author = {Jaiswal, Aruna S and Dutta, Arijit and Srinivasan, Gayathri and Yuan, Yaxia and Zhou, Daohong and Shaheen, Montaser and Sadideen, Doraid T and Kirby, Austin and Williamson, Elizabeth A and Gupta, Yogesh K and Olsen, Shaun K and Xu, Mingjiang and Loranc, Eva and Mukhopadhyay, Pramiti and Pertsemlidis, Alexander and Bishop, Alexander J R and Sung, Patrick and Nickoloff, Jac A and Hromas, Robert},
  title = {TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad952}
}
Kostenlos starten →